News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
Bitcoin bulls face make-or-break test in Lugano’s real-world payments push
Crypto.News·2025/12/26 10:54
Shiba Inu Price Prediction: Downtrend Holds As Buyers Struggle To Defend Year End Support
CoinEdition·2025/12/26 10:51
Bitcoin or Copper? Investors Reassess as Metal Outperforms Crypto in 2025
BeInCrypto·2025/12/26 10:45
Young People In Cambodia Equipped To Thrive In Digital Economy Through Video Game Development
BeInCrypto·2025/12/26 10:45
How Are Zcash Holders Positioning as Price Approaches a Major Resistance?
BeInCrypto·2025/12/26 10:45
Caroline Ellison Nears Freedom After Plea Deal Cooperation
Cointurk·2025/12/26 10:42
Vitalik Praises Idea of Linking Grok and X for Truth Optimization
CoinEdition·2025/12/26 10:42
Flash
12:56
Spot Gold Drops $14 in Short-Term Spot gold has fallen $14 in the short term, declining over 1.00% during the day, currently reported at $4133.10 per ounce. (Jin Shi)
12:52
Splash Beverage Group Inc. has successfully secured a $1 million strategic investment from C/M Capital Partners.This funding will be specifically allocated for the development of its Cannepil project.
12:51
Vivos (OTC market code: RDGL) has received Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) and will initiate a human clinical feasibility study of its Radiogel® Precision Radionuclide Therapy™.This approval marks a key step forward for the clinical application of this innovative therapy, allowing the company to begin initial safety and feasibility assessments in humans. The Radiogel® technology is designed to enable precise radiation treatment within tumors and is expected to provide a new treatment option for cancer patients. The approved clinical study will collect essential data to lay the foundation for larger-scale clinical trials in the future.